These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1659900)
21. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease. Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814 [TBL] [Abstract][Full Text] [Related]
22. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report. Icenogle TB; Peterson E; Ray G; Minnich L; Copeland JG J Heart Transplant; 1987; 6(4):199-203. PubMed ID: 2822880 [TBL] [Abstract][Full Text] [Related]
23. Acyclovir prophylaxis for cytomegalovirus disease in high-risk renal transplant recipients: is it effective? Goral S; Ynares C; Dummer S; Helderman JH Kidney Int Suppl; 1996 Dec; 57():S62-5. PubMed ID: 8941924 [TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group. Kirklin JK; Naftel DC; Levine TB; Bourge RC; Pelletier GB; O'Donnell J; Miller LW; Pritzker MR J Heart Lung Transplant; 1994; 13(3):394-404. PubMed ID: 8061014 [TBL] [Abstract][Full Text] [Related]
25. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products. Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522 [TBL] [Abstract][Full Text] [Related]
26. [Ganciclovir prophylaxis for cytomegalovirus interstitial pneumonitis after allogeneic bone marrow transplantation]. Sakai R; Maruta A; Taguchi J; Tomita N; Fujita H; Kodama F; Ogawa K; Fujisawa S; Matsuzaki M; Motomura S; Okubo T Rinsho Ketsueki; 1996 Jan; 37(1):14-21. PubMed ID: 8683862 [TBL] [Abstract][Full Text] [Related]
27. [Cytomegalovirus in liver transplantation: incidence and groups at risk]. Schiffer V; Mentha G; Giostra E; Belli D; Le Coultre C; Rohner A Schweiz Med Wochenschr; 1994 Apr; 124(15):631-6. PubMed ID: 8191266 [TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Ettinger NA; Bailey TC; Trulock EP; Storch GA; Anderson D; Raab S; Spitznagel EL; Dresler C; Cooper JD Am Rev Respir Dis; 1993 Apr; 147(4):1017-23. PubMed ID: 8385429 [TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus pneumonitis after cardiac transplantation. Schulman LL; Reison DS; Austin JH; Rose EA Arch Intern Med; 1991 Jun; 151(6):1118-24. PubMed ID: 1645949 [TBL] [Abstract][Full Text] [Related]
30. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation. Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352 [TBL] [Abstract][Full Text] [Related]
31. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. Chou SW N Engl J Med; 1986 May; 314(22):1418-23. PubMed ID: 3010114 [TBL] [Abstract][Full Text] [Related]
33. [Multivariate analysis of the risk factors of cytomegalovirus pneumonia after renal transplantation]. Wei Q; Yu LX; Deng WF; Ye JS Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1182-4. PubMed ID: 19726356 [TBL] [Abstract][Full Text] [Related]
34. The importance of cytomegalovirus in heart-lung transplant recipients. Hutter JA; Scott J; Wreghitt T; Higenbottam T; Wallwork J Chest; 1989 Mar; 95(3):627-31. PubMed ID: 2537711 [TBL] [Abstract][Full Text] [Related]
35. Primary and secondary cytomegalovirus infection. Suwansirikul S; Rao N; Dowling JN; Ho M Arch Intern Med; 1977 Aug; 137(8):1026-9. PubMed ID: 195547 [TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus pneumonitis and bone marrow transplantation: identification of a specific high risk group. Foot AB; Caul EO; Roome AP; Darville JM; Oakhill A J Clin Pathol; 1993 May; 46(5):415-9. PubMed ID: 8391547 [TBL] [Abstract][Full Text] [Related]
37. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Schulman LL; Weinberg AD; McGregor CC; Suciu-Foca NM; Itescu S Am J Respir Crit Care Med; 2001 Feb; 163(2):437-42. PubMed ID: 11179119 [TBL] [Abstract][Full Text] [Related]
38. Role of CMV pneumonia in the development of obliterative bronchiolitis in heart-lung and double-lung transplant recipients. Cerrina J; Le Roy Ladurie F; Herve PH; Parquin F; Harari S; Chapelier A; Simoneau G; Vouhe P; Dartevelle PH Transpl Int; 1992; 5 Suppl 1():S242-5. PubMed ID: 14621790 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic yield of bronchoscopies after isolated lung transplantation. Baz MA; Layish DT; Govert JA; Howell DN; Lawrence CM; Davis RD; Tapson VF Chest; 1996 Jul; 110(1):84-8. PubMed ID: 8681672 [TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus infections in heart and heart and lung transplant recipients. Wreghitt TG; Hakim M; Gray JJ; Kucia S; Wallwork J; English TA J Clin Pathol; 1988 Jun; 41(6):660-7. PubMed ID: 2838530 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]